9 patents currently held
248 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.
The next term ends in Jun 2031. from the record
Of the 248 now held by other companies, 163 name Boston Scientific Medical Device Limited as their current owner, and 85 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jun 2031
Next term end
8
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2034 · High confidence
Also notable
Ends Jun 2031 · High confidence
Also notable
Ends Aug 2036 · Low confidence
Also notable
Ends Sep 2033 · Medium confidence
Also notable
Ends Oct 2035 · High confidence
Device and Method for Delivering Medicaments
US 10,420,956
Granted 2019. Computed term ends 2034.
System and Method for Treating Tissue Wall Prolapse
US 8,900,324
Granted 2014 and renewed at every maintenance window due so far. Protection runs to 2031.
Bodily Substance Detection by Evaluating Photoluminescent Response to Excitation Radiation
US 11,672,600
Granted 2023. Computed term ends 2036. A terminal disclaimer caps this term to an earlier patent's.
Device and Method for Improving Brachytherapy
US 10,238,891
Granted 2019. Computed term ends 2033.
Catheter Delivery System for Stent Valve
US 12,427,020
A family of 5 related applications built on the 2025 grant. Too new for citation comparison; protection runs to 2035.
Formerly held, still cited
Notable
Ends Feb 2030 · High confidence
The most cited patent in this portfolio, cited by 553 later US patents, top 1% of utility patents granted in 2014 in our data. Protection runs to 2030.
now held by Boston Scientific Medical Device Limited
Also notable
Ends Mar 2033 · Medium confidence
Cited by 158 later US patents, top 1% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2033.
now held by Boston Scientific Medical Device Limited
Also notable
Ends Oct 2028 · High confidence
Cited by 132 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2028.
conveyed to Boston Scientific Scimed, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 24, 2027The maintenance fee for Device and Method for Delivering Medicaments (US 10,420,956) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- 8 terms have ended since Aug 23, 2026
- Nov 6 US 7,842,010 Pneumatically-Operated Thrombectomy Catheter Deployment System · term ended
- Oct 7 US 8,852,219 Interventional Catheters Having Cutter Assemblies and Differential Cutting Surfaces for Use in Such Assemblies · lapsed on the fee record
- Sep 20 US 11,446,059 Implant Insertion Device · lapsed on the fee record
- Sep 18 US 10,076,404 Catheter System with Balloon-Operated Filter Sheath and Fluid Flow Maintenance · lapsed on the fee record
- Sep 18 US 10,076,396 Implants, Tools, and Methods for Treatments of Pelvic Conditions · lapsed on the fee record
- Sep 16 US 8,834,350 Surgical Implants, Tools, and Methods for Treating Pelvic Conditions · lapsed on the fee record
- Sep 11 US 10,071,247 Electronic Stimulator Device Pulse Generator Circuit · lapsed on the fee record
- Aug 28 US 10,058,240 Systems, Implants, Tools, and Methods for Treatments of Pelvic Conditions · lapsed on the fee record
What they patent
The largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Bodily Substance Detection by Evaluating Photoluminescent Response to Excitation Radiation | 2 in force | to Aug 2036 |
| Medical Articulation Devices and Methods of Using the Same | 1 in force | to Jun 2042 |
| System and Method for Monitoring Fluid Deficit | 1 in force | to Mar 2041 |
| Stent Seals and Method of Production | 1 in force | to Jan 2038 |
| Catheter Delivery System for Stent Valve | 1 in force | to Oct 2035 |
| Device and Method for Delivering Medicaments | 1 in force | to Oct 2034 |
| Device and Method for Improving Brachytherapy | 1 in force | to Sep 2033 |
| System and Method for Treating Tissue Wall Prolapse | 1 in force | to Jun 2031 |
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,900,324 | System and Method for Treating Tissue Wall Prolapse In force · High confidence | In force | High confidence | |
| US 10,238,891 | Device and Method for Improving Brachytherapy In force · Medium confidence | In force | Medium confidence | |
| US 10,420,956 | Device and Method for Delivering Medicaments In force · High confidence | In force | High confidence | |
| US 12,427,020 | Catheter Delivery System for Stent Valve In force · High confidence | In force | High confidence | |
| US 12,295,655 | Bodily Substance Detection by Evaluating Photoluminescent Response to Excitation Radiation In force · High confidence | In force | High confidence | |
| US 11,672,600 | Bodily Substance Detection by Evaluating Photoluminescent Response to Excitation Radiation In force · Low confidence | In force | Low confidence | |
| US 12,156,807 | Stent Seals and Method of Production In force · High confidence | In force | High confidence | |
| US 12,403,253 | System and Method for Monitoring Fluid Deficit In force · High confidence | In force | High confidence | |
| US 12,310,558 | Medical Articulation Devices and Methods of Using the Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 248 patents in force now held by others · 276 patents ended · 15 applications pending · 74 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.